Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Ocugen Inc/

Recent news which mentions Ocugen Inc/

Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients
Tickers INNO
Tags Insurance Roundup John P/ Furey
From Business Journals
Lab Notes: Fox Chase Cancer Center researcher gets $1M grant; NRx raises funds
Tickers INNO
Tags NRX Pharmaceuticals Inc/ Medical Devices Aclaris Therapeutics Inc/
From Business Journals
Lab Notes: Wedgewood Pharmacy acquires Colorado lab; Aprea Therapeutics raises $5.5M
Tickers INNO
Tags John Karanicolas Insurance Inno
From Business Journals
Lab Notes: Drexel and Bancroft team up to advance autism research; AmerisourceBergen forms new partnership
Tickers INNO
Tags Annovis Bio Inc/ Insurance Quan A/ Vu
From Business Journals
Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study
Tickers INNO
Tags Jeff Aronin Health Care Jeffrey Dayno
From Business Journals
Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy
Tickers INNO
Tags Health Care Passage Bio Inc/ John Crawley
From Business Journals
Lab Notes: Cabaletta signs licensing deal for up to $162M; merger unites life sciences tech providers
Tickers INNO
Tags Zixuan Wang Georg Schett Michael Rosenzweig
From Business Journals
Lab Notes: Integral Molecular has first submission for new FDA pilot program; Jefferson ALS program expanding
Tickers INNO
Tags Jon T/ Holmlund Ocugen Inc/ Arun Upadhyay
From Business Journals
Ocugen's efforts to bring Covid-19 vaccine Covaxin to U.S. boosted by positive study results in children
Tags Shankar Musunuri Insurance Ocugen Inc/
From Business Journals
Lab Notes: Endo gets U.S. rights to potential knee pain drug; Optinose stock climbs after positive study results
Tickers INNO
Tags Health Care Endo International plc Medical Devices
From Business Journals
Ocugen gets rights to Mexico in expanded Covaxin deal with Bharat Biotech
Tags Biotech Health Care Pharmaceuticals
From Business Journals
Ocugen's study of Covid-19 vaccine Covaxin put on hold in wake of WHO inspection of Bharat
Tags Health Care Biotech Coronavirus
From Business Journals
Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
Tickers INNO
Tags Biotech Verrica Pharmaceuticals Inc/ PhaseBio Pharmaceuticals Inc/
From Business Journals
Lab Notes: Chimeron's Covid-19 vaccine candidate shows promise; Lannett gets 2nd NYSE delisting notice
Tickers INNO
Tags Ocugen Inc/ Lannett Co/ Inc/ Lannett Co Inc
From Business Journals
Ocugen's stock plummets after FDA rejects emergency use bid for Covid vaccine
Tags Biotech Health Care Pharmaceuticals
From Business Journals
Ocugen expects $53.5M from stock sale amid efforts to bring Covaxin to the U.S.
Tags Ocugen Inc/ Insurance Pharmaceuticals
From Business Journals
Ocugen signs letter of intent to buy Canadian pharmaceutical manufacturing plant
Tags Ocugen Inc/ Insurance Shankar Musunuri
From Business Journals
Lab Notes: Strata Skin Sciences makes acquisition; Cabaletta Bio promotes 2 executives
Tickers INNO
Tags Health Care Cabaletta Bio, Inc/ Tom Tillett
From Business Journals
Lab Notes: Trevena advances new pain drug; Ocugen receives good news from FDA
Tickers INNO
Tags Avantor Inc/ Bruce Peacock Phil Johnson
From Business Journals
FDA places a hold on Ocugen's plan for U.S. trials of the Covid-19 vaccine Covaxin
Tags Ocugen Inc/ Insurance Pharmaceuticals
From Business Journals
Ocugen applies for emergency FDA authorization for use of its Covid-19 vaccine in children
Tags Pharmaceuticals Coronavirus Biotech
From Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
Tickers INNO
Tags Windtree Therapeutics, Inc/ Roundup Inovio Pharmaceuticals Inc/
From Business Journals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.